APO RESEARCH · REPORT
Pharma and Health Care
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Product & engineering
Understand the product.
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Selected research
Industry Research
Pharma and Health Care Industry Research Report 2026
Market perspective
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
Report Scope
This report quantifies the global Pharma and Health Care market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharma and Health Care.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma and Health Care Market by Company
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Pharma and Health Care Segment by Format
Bottle
Blister
Others
Pharma and Health Care Segment by Prescription
OTC Drugs
Prescription Drugs
Pharma and Health Care Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bottle
- Blister
- Others
Applications
- OTC Drugs
- Prescription Drugs
Companies covered
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Merck & Co.
- Bristol Myers Squibb
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- AstraZeneca
- Bayer
- Eli Lilly & Co.
- Gilead Sciences
- Amgen
- Novo Nordisk
- Teva
- Boehringer Ingelheim
- Biogen
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharma and Health Care by Format
- 2.2.1 Market Value Comparison by Format (2021 VS 2025 VS 2032)
- 2.2.2 Bottle
- 2.2.3 Blister
- 2.2.4 Others
- 2.3 Pharma and Health Care by Prescription
- 2.3.1 Market Value Comparison by Prescription (2021 VS 2025 VS 2032)
- 2.3.2 OTC Drugs
- 2.3.3 Prescription Drugs
- 2.4 Assumptions and Limitations
3 Pharma and Health Care Breakdown Data by Format
- 3.1 Global Pharma and Health Care Historic Market Size by Format (2021-2026)
- 3.2 Global Pharma and Health Care Forecasted Market Size by Format (2027-2032)
4 Pharma and Health Care Breakdown Data by Prescription
- 4.1 Global Pharma and Health Care Historic Market Size by Prescription (2021-2026)
- 4.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharma and Health Care Market Perspective (2021-2032)
- 5.2 Global Pharma and Health Care Growth Trends by Region
- 5.2.1 Global Pharma and Health Care Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharma and Health Care Historic Market Size by Region (2021-2026)
- 5.2.3 Pharma and Health Care Forecasted Market Size by Region (2027-2032)
- 5.3 Pharma and Health Care Market Dynamics
- 5.3.1 Pharma and Health Care Industry Trends
- 5.3.2 Pharma and Health Care Market Drivers
- 5.3.3 Pharma and Health Care Market Challenges
- 5.3.4 Pharma and Health Care Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharma and Health Care Players by Revenue
- 6.1.1 Global Top Pharma and Health Care Players by Revenue (2021-2026)
- 6.1.2 Global Pharma and Health Care Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharma and Health Care Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharma and Health Care Head Office and Area Served
- 6.4 Global Pharma and Health Care Players, Product Type & Application
- 6.5 Global Pharma and Health Care Manufacturers Established Date
- 6.6 Global Pharma and Health Care Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharma and Health Care Market Size (2021-2032)
- 7.2 North America Pharma and Health Care Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharma and Health Care Market Size by Country (2021-2026)
- 7.4 North America Pharma and Health Care Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharma and Health Care Market Size (2021-2032)
- 8.2 Europe Pharma and Health Care Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharma and Health Care Market Size by Country (2021-2026)
- 8.4 Europe Pharma and Health Care Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharma and Health Care Market Size (2021-2032)
- 9.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharma and Health Care Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharma and Health Care Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharma and Health Care Market Size (2021-2032)
- 10.2 South America Pharma and Health Care Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharma and Health Care Market Size by Country (2021-2026)
- 10.4 South America Pharma and Health Care Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharma and Health Care Market Size (2021-2032)
- 11.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharma and Health Care Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharma and Health Care Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Pharma and Health Care Business (2021-2026)
- 12.1.4 Johnson & Johnson Pharma and Health Care Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 Novartis
- 12.2.1 Novartis Company Information
- 12.2.2 Novartis Business Overview
- 12.2.3 Novartis Revenue in Pharma and Health Care Business (2021-2026)
- 12.2.4 Novartis Pharma and Health Care Product Portfolio
- 12.2.5 Novartis Recent Developments
- 12.3 Roche
- 12.3.1 Roche Company Information
- 12.3.2 Roche Business Overview
- 12.3.3 Roche Revenue in Pharma and Health Care Business (2021-2026)
- 12.3.4 Roche Pharma and Health Care Product Portfolio
- 12.3.5 Roche Recent Developments
- 12.4 AbbVie
- 12.4.1 AbbVie Company Information
- 12.4.2 AbbVie Business Overview
- 12.4.3 AbbVie Revenue in Pharma and Health Care Business (2021-2026)
- 12.4.4 AbbVie Pharma and Health Care Product Portfolio
- 12.4.5 AbbVie Recent Developments
- 12.5 Merck & Co.
- 12.5.1 Merck & Co. Company Information
- 12.5.2 Merck & Co. Business Overview
- 12.5.3 Merck & Co. Revenue in Pharma and Health Care Business (2021-2026)
- 12.5.4 Merck & Co. Pharma and Health Care Product Portfolio
- 12.5.5 Merck & Co. Recent Developments
- 12.6 Bristol Myers Squibb
- 12.6.1 Bristol Myers Squibb Company Information
- 12.6.2 Bristol Myers Squibb Business Overview
- 12.6.3 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2021-2026)
- 12.6.4 Bristol Myers Squibb Pharma and Health Care Product Portfolio
- 12.6.5 Bristol Myers Squibb Recent Developments
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Company Information
- 12.7.2 GlaxoSmithKline Business Overview
- 12.7.3 GlaxoSmithKline Revenue in Pharma and Health Care Business (2021-2026)
- 12.7.4 GlaxoSmithKline Pharma and Health Care Product Portfolio
- 12.7.5 GlaxoSmithKline Recent Developments
- 12.8 Pfizer
- 12.8.1 Pfizer Company Information
- 12.8.2 Pfizer Business Overview
- 12.8.3 Pfizer Revenue in Pharma and Health Care Business (2021-2026)
- 12.8.4 Pfizer Pharma and Health Care Product Portfolio
- 12.8.5 Pfizer Recent Developments
- 12.9 Sanofi
- 12.9.1 Sanofi Company Information
- 12.9.2 Sanofi Business Overview
- 12.9.3 Sanofi Revenue in Pharma and Health Care Business (2021-2026)
- 12.9.4 Sanofi Pharma and Health Care Product Portfolio
- 12.9.5 Sanofi Recent Developments
- 12.10 Takeda
- 12.10.1 Takeda Company Information
- 12.10.2 Takeda Business Overview
- 12.10.3 Takeda Revenue in Pharma and Health Care Business (2021-2026)
- 12.10.4 Takeda Pharma and Health Care Product Portfolio
- 12.10.5 Takeda Recent Developments
- 12.11 AstraZeneca
- 12.11.1 AstraZeneca Company Information
- 12.11.2 AstraZeneca Business Overview
- 12.11.3 AstraZeneca Revenue in Pharma and Health Care Business (2021-2026)
- 12.11.4 AstraZeneca Pharma and Health Care Product Portfolio
- 12.11.5 AstraZeneca Recent Developments
- 12.12 Bayer
- 12.12.1 Bayer Company Information
- 12.12.2 Bayer Business Overview
- 12.12.3 Bayer Revenue in Pharma and Health Care Business (2021-2026)
- 12.12.4 Bayer Pharma and Health Care Product Portfolio
- 12.12.5 Bayer Recent Developments
- 12.13 Eli Lilly & Co.
- 12.13.1 Eli Lilly & Co. Company Information
- 12.13.2 Eli Lilly & Co. Business Overview
- 12.13.3 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2021-2026)
- 12.13.4 Eli Lilly & Co. Pharma and Health Care Product Portfolio
- 12.13.5 Eli Lilly & Co. Recent Developments
- 12.14 Gilead Sciences
- 12.14.1 Gilead Sciences Company Information
- 12.14.2 Gilead Sciences Business Overview
- 12.14.3 Gilead Sciences Revenue in Pharma and Health Care Business (2021-2026)
- 12.14.4 Gilead Sciences Pharma and Health Care Product Portfolio
- 12.14.5 Gilead Sciences Recent Developments
- 12.15 Amgen
- 12.15.1 Amgen Company Information
- 12.15.2 Amgen Business Overview
- 12.15.3 Amgen Revenue in Pharma and Health Care Business (2021-2026)
- 12.15.4 Amgen Pharma and Health Care Product Portfolio
- 12.15.5 Amgen Recent Developments
- 12.16 Novo Nordisk
- 12.16.1 Novo Nordisk Company Information
- 12.16.2 Novo Nordisk Business Overview
- 12.16.3 Novo Nordisk Revenue in Pharma and Health Care Business (2021-2026)
- 12.16.4 Novo Nordisk Pharma and Health Care Product Portfolio
- 12.16.5 Novo Nordisk Recent Developments
- 12.17 Teva
- 12.17.1 Teva Company Information
- 12.17.2 Teva Business Overview
- 12.17.3 Teva Revenue in Pharma and Health Care Business (2021-2026)
- 12.17.4 Teva Pharma and Health Care Product Portfolio
- 12.17.5 Teva Recent Developments
- 12.18 Boehringer Ingelheim
- 12.18.1 Boehringer Ingelheim Company Information
- 12.18.2 Boehringer Ingelheim Business Overview
- 12.18.3 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2021-2026)
- 12.18.4 Boehringer Ingelheim Pharma and Health Care Product Portfolio
- 12.18.5 Boehringer Ingelheim Recent Developments
- 12.19 Biogen
- 12.19.1 Biogen Company Information
- 12.19.2 Biogen Business Overview
- 12.19.3 Biogen Revenue in Pharma and Health Care Business (2021-2026)
- 12.19.4 Biogen Pharma and Health Care Product Portfolio
- 12.19.5 Biogen Recent Developments
- 12.20 Astellas
- 12.20.1 Astellas Company Information
- 12.20.2 Astellas Business Overview
- 12.20.3 Astellas Revenue in Pharma and Health Care Business (2021-2026)
- 12.20.4 Astellas Pharma and Health Care Product Portfolio
- 12.20.5 Astellas Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst